Description

Incruse Ellipta is a medication used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It contains the active ingredient umeclidinium, which is a long-acting muscarinic antagonist that helps to relax the muscles in the airways and improve breathing.

Interpreter Notes

Interpreters should be aware that 'Incruse Ellipta' may be referred to by its active ingredient, umeclidinium, in some contexts. It is important to maintain a formal tone and ensure clarity when discussing this medication, as patients may confuse it with other respiratory treatments. Avoid colloquial terms that may arise in regional dialects.

Example Sentences

EN: The doctor prescribed Incruse Ellipta to help manage the patient's COPD symptoms.

ES: El médico recetó Incruse Ellipta para ayudar a controlar los síntomas de la EPOC del paciente.

Common Interpreter Mistakes

Confusing Incruse Ellipta with other COPD medications; mispronouncing 'Incruse' as 'incruse'; using informal language when discussing the medication.